PTPN2 and inflammatory bowel disease: To demonstrate how low-usage sQTLs can dysregulate alternative splicing and predispose to IMDs, we further investigated a PTPN2 sQTL that implicates a lowly-used intron that colocalised with an inflammatory bowel disease (IBD) associated risk locus at 18p11.21 (Fig. 6a).